Get started
AMGEN 20/25AMGEN 20/25AMGEN 20/25

AMGEN 20/25

No trades
See on Supercharts
Overview
Analysis News

AMGB chart


Full chart

Key terms


Outstanding amount
‪500.00 M‬ USD
Face value
1,000.00 USD
Minimum denomination
2,000.00 USD
Coupon
1.90% (Fixed)
Coupon frequency
Semi-annual
Yield to maturity
5.51%
Maturity date
Feb 21, 2025
Term to maturity
3 months

About AMGEN 20/25


Issuer
Amgen, Inc.
Sector
Health Technology
Industry
Biotechnology
Home page
amgen.com
Issue date
Feb 21, 2020
FIGI
BBG00RRV3C84
Amgen, Inc. is a biotechnology company, which engages in the discovery, development, manufacture, and marketing of human therapeutics. It operates through Human Therapeutics segment. The company was founded by William K. Bowes, Jr., Franklin Pitcher Johnson, Jr., George B. Rathmann, and Joseph Rubinfeld on April 8, 1980 and is headquartered in Thousand Oaks, CA.

AMGB analysis


Advanced bond data for paid plans
Unlock important bond data including coupon rates, redemption details, risk assessments, and much more.

AMGB news